For Immediate Release
Contact: Jeanne Thomson
847.836.3330
jthomson@logica3.com
Momenta Pharmaceuticals Selects Logica3 to Design Annual Report
West Dundee, IL—July 10, 2007—Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, selected Logica3 for the second consecutive year to design and produce its annual report.
“Momenta is a tremendously exciting company,” said Lisa Dombrowski, president of Logica3. “Their proprietary technology enables the discovery and development of drugs that will potentially benefit millions of people worldwide. We are pleased that they have asked us to continue helping them tell their story.”
The annual report visuals and theme, “Going Beyond,” illustrate the breadth of Momenta’s success as the company moves to the next stages in research, development and clinical trials. According to Craig A. Wheeler, Momenta’s Chief Executive Officer, “The theme captures the exciting potential of our company to create future product opportunities.”
“At Momenta, we believe that our technology and business model enable us to transcend the conventional boundaries of biotechnology companies,” stated Mike Lawless, Senior Director of Investor Relations. “Logica3 continually transforms the abstract scientific details of our business into a creative and compelling message.”
Momenta Pharmaceuticals, Inc. was founded in 2001 based on technology initially developed at Massachusetts Institute of Technology and is headquartered in Cambridge, Massachusetts.